Product information

From Health Canada

New search

The product monograph is developed by a drug sponsor according to guidelines published by Health Canada that provide direction on the content and format. The veterinary labelling is developed by the drug sponsor according to the Food and Drug Regulations. While Health Canada reviews the product monograph or the veterinary labelling as part of the drug review process, it remains the responsibility of the drug sponsor to ensure that the product monograph or the veterinary labelling is complete and accurate.

Current status:

Marketed

Current status date:

2006-05-15

Original market date: See footnote 1

1979-12-31

Product name:

M-M-R II

Help on accessing alternative formats, such as Portable Document Format (PDF), Microsoft Word and PowerPoint (PPT) files, can be obtained in the alternate format help section .

DIN:

00466085

Product Monograph/Veterinary Labelling:

Date: 2021-03-17 Product monograph/Veterinary Labelling (PDF version ~ 175K)

Company: 

MERCK CANADA INC
16750 Route Transcanadienne
Kirkland
Quebec
Canada  H9H 4M7

Class: 

Human

Dosage form(s):

Powder For Solution

Route(s) of administration:

Subcutaneous

Number of active ingredient(s):

3

Schedule(s):

Schedule D  

Biosimilar Biologic Drug:

No

American Hospital Formulary Service (AHFS): See footnote 3

80:12.00   VACCINES

Anatomical Therapeutic Chemical (ATC): See footnote 4

J07BD52  MEASLES,COMBIN. WITH MUMPS AND RUBELLA,LIVE ATTENUATED

Active ingredient group (AIG) number:See footnote 5

0343701001

List of active ingredient(s)
Active ingredient(s) Strength
MEASLES VIRUS VACCINE LIVE ATTENUATED 1000 UNIT / 0.5 ML
MUMPS VIRUS VACCINE LIVE ATTENUATED (JERYL LYNN STRAIN) 5000 UNIT / 0.5 ML
RUBELLA VIRUS VACCINE LIVE ATTENUATED (WISTAR RA27/3 STRAIN) 1000 UNIT / 0.5 ML

Application information

Related information

Contact us

Version 3.8.0
Date modified: